Which has the lower trailing P/E, DOV or PFE?

PFE has the lower trailing P/E: DOV trades at 24.86 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DOV or PFE?

Over the past five years, PFE grew revenue faster — DOV at a 2.54% CAGR versus PFE at 8.22%.

Does DOV or PFE pay a bigger dividend?

DOV yields 1.01% and PFE yields 6.97% based on trailing dividends and the latest price.

Is DOV or PFE more profitable?

DOV runs the higher net margin — DOV at 13.48% versus PFE at 11.83%.

How have DOV and PFE total returns compared?

Over the past 10 years, DOV delivered 15.37% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.

Dover Corporation (DOV) vs Pfizer Inc. (PFE)

A side-by-side comparison of Dover Corporation and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: DOV is classified in Industrials; PFE is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

DOV

Dover Corporation

$27.35B

$203.08IndustrialsDelayed quote: Jul 28, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$143.91B

$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT

Total return — DOV vs PFE

growth of $100 · dividends reinvested · last 30y

DOV +2287.5%PFE +562.5%DOV compounded faster

DOV PFE

DOV vs PFE: by the numbers

•PFE is the larger company ($143.91B vs $27.35B market cap).
•PFE trades at the lower trailing earnings multiple (18.83 vs 24.86 P/E), one valuation lens rather than an overall verdict.
•DOV converts more revenue to profit (13.48% vs 11.83% net margin).
•PFE grew revenue faster over the past five years (8.22% vs 2.54% CAGR).
•PFE pays the higher dividend yield (6.97% vs 1.01%).

Metrics side by side

Valuation

Metric	DOV	PFE
P/E ratio	24.86	18.83
Forward P/E	19.27	8.38
P/S ratio	3.31	2.23
P/B ratio	3.62	1.57
PEG ratio	2.27	N/A
EV / EBITDA	17.14	9.72
FCF yield	4.21%	6.71%

Profitability

Metric	DOV	PFE
Gross margin	39.58%	69.35%
Operating margin	16.87%	23.45%
Net margin	13.48%	11.83%
ROE	14.73%	8.31%
ROIC	9.40%	8.84%

Dividends

Metric	DOV	PFE
Dividend yield	1.01%	6.97%
Payout ratio	26.10%	126.47%

Growth (annualized)

Metric	DOV	PFE
Revenue CAGR (5Y)	2.54%	8.22%
EPS CAGR (5Y)	10.95%	-3.78%
FCF CAGR (5Y)	2.56%	-3.79%
Total return CAGR (5Y)	6.04%	-5.21%

Frequently asked

Which has the lower trailing P/E, DOV or PFE?: PFE has the lower trailing P/E: DOV trades at 24.86 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DOV or PFE?: Over the past five years, PFE grew revenue faster — DOV at a 2.54% CAGR versus PFE at 8.22%.
Does DOV or PFE pay a bigger dividend?: DOV yields 1.01% and PFE yields 6.97% based on trailing dividends and the latest price.
Is DOV or PFE more profitable?: DOV runs the higher net margin — DOV at 13.48% versus PFE at 11.83%.
How have DOV and PFE total returns compared?: Over the past 10 years, DOV delivered 15.37% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DOV analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Dover P/E ratio Pfizer P/E ratio Dover dividend yield Pfizer dividend yield Dover ROE Pfizer ROE Dover operating margin Pfizer operating margin Dover revenue growth Pfizer revenue growth Dover free cash flow Pfizer free cash flow

Dover & Pfizer appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.